Ribavirin in the treatment of SARS: A new trick for an old drug?

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 10, 2003, Pages 1289-1292

  Koren, Gideon ^a   King, Susan ^a   Knowles, Sandra ^b   Phillips, Elizabeth ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; METHYLPREDNISOLONE; OSELTAMIVIR; RIBAVIRIN; STAVUDINE; WARFARIN; ZIDOVUDINE;

ANEMIA; BRONCHITIS; BRONCHOSPASM; CLINICAL TRIAL; CONJUNCTIVITIS; CORONAVIRUS; CREATININE CLEARANCE; CRUSH SYNDROME; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DYSPNEA; HEADACHE; HEMORRHAGIC FEVER; HEPATITIS C; HUMAN; HYPERCAPNIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOXEMIA; LASSA FEVER; NAUSEA; PNEUMONIA; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TERATOGENICITY; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0038413938     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Cameron CE, Castro C. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr Opin Infect Dis 2001;14:757-64.
2. Glue P. The clinical pharmacology of ribavirin. Semin Liver Dis 1999;19:17-24.
3. Smith DW, Frankel LR, Mathers LH, Tang AT, Arigno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991;325:24-9.
4. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, et al. Prospective, double blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-27.
5. National Institutes of Health consensus development conference statement. Management of hepatitis C: 2002. Bethesda (MD): National Institutes of Health; 2002. www.consensus.nih.gov/cons/116/Hepc091202.pdf (accessed 2003 Apr 15).
6. Chang CH, Chen KY, Lai MY, Chan KA. Meta-analysis: ribavirin-induced hemolytic anaemia in patients with chronic hepatitis C. Aliment Pharmacol Ther 2002;16:1623-32.
7. Lafeuillade A, Hittinger G, Chadapaud S. Increased mitochondrial toxicity with ribavirin in HIV/HCV colnfection. Lancet 2001;357:280-1.
8. Pockros PJ, Reindollar R, McHutchinson J, Reddy R, Wright T, Boyd DG, et al. The safety and tolerability of daily infergen plus ribavirin in the treatment of naïve chronic hepatitis C patients. J Viral Hepat 2003;10:55-60.
9. Bertrand P, Faro A, Cantwell P, Tzakis A. Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus. Pharmacotherapy 2000;20:1296.
10. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther 1999;4:211-9.
11. Chutaputti A. Management of hepatitis C: adverse effects and other safety aspects of the hepatitis C antivirals. J Gastroenterol Hepatol 2000;15(Suppl):E156-63.
12. Schulman S. Inhibition of warfarin activity by ribavirin. Ann Pharmacother 2002;36:72-4.
13. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Ribavirin: Is there a risk to hospital personnel? [position statement]. CMAJ 1991;144(3):285-6.
14. Ito S, Koren G. Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations. Pediatr Infect Dis J 1993;12:2-5.
15. Office of Women's Health. Promoting healthy pregnancies [Web page]. Rockville (MD): US Food and Drug Administration; 2003. Available: www.fda.gov/womens/registries/ (accessed 2003 Apr 16).
16. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, et al. Identification of severe acute respiratory syndrome in Canada [online]. N Engl J Med. Available: content.nejm.org/cgi/reprint/NEJMoa030634v3 (posted 2003 Mar 31; accessed 2003 Apr 15).
17. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong [online]. N Engl J Med. Available: content.nejm.org/cgi/reprint/NEJMoa030666v3 (posted 2003 Mar 31; accessed 2003 Apr 15).
18. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong [online]. N Engl J Med. Available: content.nejm.org/cgi/reprint/NEJMoa030685v2 (posted 2003 Apr 7; accessed 2003 Apr 15).